Pregnancy Registry Recruitment Notices Should Be Cleared By FDA - Guidance
Executive Summary
Manufacturers will need to balance the "active recruitment" strategies for pregnancy registries urged by FDA with the agency's warning that recruitment efforts must not promote product use in pregnant women.
You may also be interested in...
Pregnancy Registry Data Use In Labeling Should Be Compiled By FDA - PhRMA
FDA should document the historical usefulness of pregnancy registry data to product labeling decisions before proceeding with its recently released pregnancy registry draft guidances, the Pharmaceutical Research & Manufacturers of America said in Aug. 31 comments to the agency.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011